Researchers have mapped how lung damage begins early in life for children with cystic fibrosis, providing new insights that will help reshape future care. The research team, led by Murdoch Children's ...

Cystic fibrosis is one of the most common genetic disorders, causing thick mucus build-up in the lungs and other parts of the body, breathing problems, and infection. Now, researchers have developed a ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in life, presumably even in ...

A CRISPR gene-editing therapy has the potential to offer an effective, long-lasting treatment for cystic fibrosis after overcoming a major challenge that held back previous genetic therapies. The ...

In patients with cystic fibrosis (CF), the occurrence of pulmonary exacerbations requiring intensive therapy (PERITs) was associated with marked decline in lung function that was not always reversed ...

The development of gene editing tools, which enable the specific targeting and correction of mutations, hold the promise of allowing us to correct those mutations that cause genetic diseases. However, ...

Please provide your email address to receive an email when new articles are posted on . Researchers captured exercise capacity measures during the first week of pulmonary rehabilitation to the session ...

Researchers have mapped how lung damage begins early in life for children with cystic fibrosis, providing new insights that will help reshape future care.